Vor Biopharma Inc. has announced a key management change with the appointment of Robert Ang, the company's President and Chief Executive Officer, as the new principal financial officer and principal accounting officer. The decision was made by the Board of Directors on May 19, 2024. Dr. Ang, who is also a director of the company, will now assume additional responsibilities in overseeing the company's financial and accounting functions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.